• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Bio-Medical Sciences (Bio-Medical)
    • School of Bio-Medical Sciences (Bio-Medical) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Bio-Medical Sciences (Bio-Medical)
    • School of Bio-Medical Sciences (Bio-Medical) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Monocyte activation and dysregulation in treated and untreated hiv-1 infected Ugandans.

    Thumbnail
    View/Open
    MAIN ARTICLE (2.087Mb)
    Date
    2018-08-30
    Author
    Nabuuma, Haawa
    Metadata
    Show full item record
    Abstract
    Introduction: Mechanism for increased non-AIDs co morbidities in HIV-1infected individuals on combinatorial antiretroviral therapy (cART) still requires exploration. This is majorly attributed to chronic monocyte activation and inflammation that persist regardless of effective HIV-1 therapy [5]. Monocytes mediate inflammation and so are crucial in development of non-AIDS co morbidities like cardiovascular disease (CVD) [7-9]. More explorative efforts are still needed to understand the mechanisms underlying monocyte related immune activation in these individuals here in Uganda. In this study, we investigated monocyte subsets, their phenotypic and functional variations as predictors of non- AIDs related illnesses amongst treated HIV-I infected Ugandans. Methods; This was a nested cross sectional study. Using flow cytometry, we determined and compared; i) subsets variation (using HLA-DR, CD14 and CD16 expression) ii) activation phenotypes using CD163, CD80 and PDL-1 expression and iii) intracellular cytokine(IL-10,IL-6 and TNF-α) production of monocyte subsets in PBMC samples of treated HIV-1 infected individuals. Results; HAART naïve HIV-Infected individuals showed increased percentages with statistical significance of nonclassical (CD14+CD16++) monocyte subsets (p=0.0264). Both intermediate and classical subsets were increased but showed no statistical significance. HAART naïve HIV-1 infected individuals also showed increased phenotypic marker (CD163,CD80,PDL-1) expression in both non-classical CD14+CD16++ (p=0.03, p=0.0234, p=0.0234) and intermediate CD14++CD16+ (p=0.0156, p=0.0163, p=0.0156) monocyte subsets, with reduction in expression for classical subsets (p=0.1484, p>0.999) respectively. The mean percentages of cytokines IL10 and TNF-α produced were increased with statistical significance in non-classical CD14+CD16++ (p=0.8438, p=0.00391), intermediate CD14++CD16+ (p=0.250, p=0.0068) and classical CD14++CD16- (p=0.0078, p=0.0 156) subsets in HAART naïve individuals in comparison to HAART treated individuals. On the contrary, IL-6 produced by non-classical subsets showed no significance for both HIV-1 infected groups (p=0.1094).
    URI
    http://hdl.handle.net/10570/7899
    Collections
    • School of Bio-Medical Sciences (Bio-Medical) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV